menu search

APM / Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022

Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, CEO and Executive Director of Aptorum Group will present both in-person and virtually at the H.C. Wainwright Global Investment Conference, New York, being held on September 13-16, 2022. Aptorum Group management will be Read More
Posted: Aug 25 2022, 20:31
Author Name: Business Wire
Views: 111440

APM News  

Why Is Aptorum (APM) Stock Down 16% Today?

By InvestorPlace
May 8, 2023

Why Is Aptorum (APM) Stock Down 16% Today?

Aptorum (NASDAQ: APM ) stock is falling on Monday after the company received a delisting notice from the Nasdaq Stock Market LLC. The reason given for more_horizontal

Aptorum Group shares double after merger plans, earnings delight investors

By Proactive Investors
May 3, 2023

Aptorum Group shares double after merger plans, earnings delight investors

Aptorum Group saw its market capitalization double following a busy week where the biopharmaceutical firm released its latest results and announced a more_horizontal

Why Is Aptorum (APM) Stock Up 166% Today?

By InvestorPlace
May 3, 2023

Why Is Aptorum (APM) Stock Up 166% Today?

Aptorum (NASDAQ: APM ) stock is climbing higher on Wednesday despite a lack of news from the clinical-stage biopharmaceutical company. However, tradin more_horizontal

Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022

By Business Wire
August 25, 2022

Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedica more_horizontal

Aptorum Stock (APM): Why The Price Surged Up Today

By Pulse2
January 25, 2022

Aptorum Stock (APM): Why The Price Surged Up Today

The stock price of Aptorum Group Ltd (NASDAQ: APM) increased by over 34% during intraday trading today. This is why it happened. more_horizontal

Aptorum Stock (APM): Why The Price Surged Up Today

By Pulse2
January 25, 2022

Aptorum Stock (APM): Why The Price Surged Up Today

The stock price of Aptorum Group Ltd (NASDAQ: APM) increased by over 34% during intraday trading today. This is why it happened. more_horizontal

Aptorum Stock (APM): Why The Price Surged Up Today

By Pulse2
January 25, 2022

Aptorum Stock (APM): Why The Price Surged Up Today

The stock price of Aptorum Group Ltd (NASDAQ: APM) increased by over 34% during intraday trading today. This is why it happened. more_horizontal

Aptorum Stock (APM): Why The Price Surged Today

By Pulse2
January 20, 2022

Aptorum Stock (APM): Why The Price Surged Today

The stock price of Aptorum Group Ltd (NASDAQ: APM) increased 38.52% today. This is why it happened. more_horizontal


Search within

Pages Search Results: